ESR1 and breast cancer: We then compared the distribution of POU2F3-positive cells and cells expressing ER, CK5 (a basal marker), and oncogenes often expressed in tuft cell-like cancers (BCL2 and KIT [13]) to ask whether the POU2F3-positive cells had a phenotype similar to tuft cell-like breast cancers.